COVID-19, DOCTORS SPEAK OUT, W.H.O./GREAT RESET/4IR, 5G, DIGITAL ID, VACCINE, FOOD SUPPLY, TRACKING & TRACING...

Frank Badfinger

Superstar
Joined
Aug 4, 2019
Messages
16,114
Some COVID-19 tests contain EtO-poison

Screenshot_2021-03-28 Some COVID-19 tests contain EtO-poison.png
 

elsbet

Superstar
Joined
Jun 4, 2017
Messages
5,122

Frank Badfinger

Superstar
Joined
Aug 4, 2019
Messages
16,114
A great presentation here from BizNews

Worthwhile presentation but the speaker never mentioned that SARS CoV-2 has never been isolated or proven to exist, thus has never been proven to be the cause of CV-19. All the case and death numbers don't mean a thing when you factor in the high cycling threshold of the PCR and manipulation of data by padding the numbers to include many other illnesses under the CV-19 banner.
Another thing that was missing was about the mRNA technology and the deadly past history of these kind of so called vaccines. Even the Great Barrington Declaration is pro-jab. While the creation of an authoritarian world order is one of the goals here, it is clear that eugenics/population reduction/genocide are equally part of the plan.

Interesting how the "virus" respects invisible boundaries of neighboring countries.
Screenshot_2021-03-29 The UGLY truth about the Covid-19 lockdowns - Nick Hudson, co-founder of...png
 
Last edited:

Frank Badfinger

Superstar
Joined
Aug 4, 2019
Messages
16,114
Arizona Governor Lifts Mask Mandates & All COVID Restrictions

Screenshot_2021-03-29 Arizona Governor Lifts Mask Mandates All COVID Restrictions.png
 

Frank Badfinger

Superstar
Joined
Aug 4, 2019
Messages
16,114

floss

Star
Joined
Mar 26, 2017
Messages
2,255
A small win today...

Went to WalMart and saw a lady about to walk in the door with a mask on her hand. I had an impression that she was sick of that crap. I sped up in front of her and made it clear that I'm about to walk inside maskless. I went inside and looked behind me, she walked in without a mask! Halelujah!
 
Joined
Dec 11, 2020
Messages
66
Evening friends

Every person we try to wake up goes through the same stages of denial and hopefully, eventually, acceptance. Some people we talk to really want to know everything you explain (absolutely understand, they have been lied to before!)

I'm in the middle of an intensive conversation around mrna with a friend, who wants to see the previous studies around animals particularly ferrets and mrna tests, when reintroduced to the virus.
But, typically, can I find the paper.?? Nope!
Typical when I save so much, I can't find this one..
Can I call for aid!

Thanks all
 

Frank Badfinger

Superstar
Joined
Aug 4, 2019
Messages
16,114

suspend the use for individuals under the age of 55, so they don't care about the elderly?
I wrote this in a comment section and the comment was banned.

"The province will carry on with injections for those between 55 and 64 because, as Reimer said, the risks of catching the virus and the severe outcomes it can lead to outweighs the risk of the rare blood-clotting events."

For a so called virus with a 99.7% recovery rate for people under 70 yrs. A virus that can be eradicated with Hydroxychloroquine or Ivermectin and prevented with regular Vit.D supplementation.

Get your blood clot shot! This is criminal.
 

Frank Badfinger

Superstar
Joined
Aug 4, 2019
Messages
16,114
Evening friends

Every person we try to wake up goes through the same stages of denial and hopefully, eventually, acceptance. Some people we talk to really want to know everything you explain (absolutely understand, they have been lied to before!)

I'm in the middle of an intensive conversation around mrna with a friend, who wants to see the previous studies around animals particularly ferrets and mrna tests, when reintroduced to the virus.
But, typically, can I find the paper.?? Nope!
Typical when I save so much, I can't find this one..
Can I call for aid!

Thanks all
I think this is what you are looking for.


This is found near the end of the study.

This combined experience provides concern for trials with SARS-CoV vaccines in humans. Clinical trials with SARS coronavirus vaccines have been conducted and reported to induce antibody responses and to be “safe” [29], [30]. However, the evidence for safety is for a short period of observation. The concern arising from the present report is for an immunopathologic reaction occurring among vaccinated individuals on exposure to infectious SARS-CoV, the basis for developing a vaccine for SARS. Additional safety concerns relate to effectiveness and safety against antigenic variants of SARS-CoV and for safety of vaccinated persons exposed to other coronaviruses, particularly those of the type 2 group. Our study with a VLP SARS vaccine contained the N protein of mouse hepatitis virus and Bolles, et al., reported the immunopathology in mice occurs for heterologous Gp2b CoV vaccines after challenge [25]. This concern emanates from the proposal that the N protein may be the dominant antigen provoking the immunopathologic reaction.

Because of well documented severity of the respiratory disease among infants given an inactivated RSV vaccine and subsequently infected with RSV that is considered to be attributable to a Th2-type immunopathologic reaction and a large number of studies in the Balb/c mouse model that have described and elucidated many components of the immunopathologic reaction to RSV vaccines, the similarity to the SARS-CoV vaccine evaluations in Balb/c mice supports caution for clinical vaccine trials with SARS-CoV vaccines in humans. Of interest are the similar occurrences in C57BL/6 mice and in ferrets and nonhuman primates that provide alternative models for elucidating vaccine-induced mechanisms for occurrences of Th2 immunopathologic reactions after infection. As indicated, strong animal model evidence indicates expression of the N protein by SARS-CoV vector vaccines can induce sensitization leading to a Th2–type immunopathology with infection. In contrast to our results, those studies did not find clear evidence of the Th2 type immunopathology on challenge of mice given a vector vaccine for the S protein. The finding of a Th-2-type pathology in our studies in animals immunized with an rDNA-produced S protein is unequivocal. In this regard, animal model studies with FIPV in cats and RSV in mice have indicated that viral surface proteins may be the sensitizing protein of inactivated vaccines for immunopathology with infection [32], [45]. This suggests that presentation of the S protein in a vector format may direct immune responses in a different way so that sensitization does not occur.

Limitations of the present studies include their performance in mice only and uncertainty of the relevance of rodent models to SARS-CoV vaccines in humans. Additionally, a more intense study for virus replication including quantitative RT-PCR assays might have confirmed the probability that virus replication is required for induction of the immunopathology after vaccination. Evaluations of mechanisms for the immunopathology, including immunoglobulin and cytokine responses to vaccines and tests for antigen-antibody complexes in tissues exhibiting the reaction, could have strengthened the Th2-type immunopathology finding. Finally, a successful study with a Th1-type adjuvant that did not exhibit the Th2 pathology after challenge would have confirmed a Th2 bias to immune responses as well as provide a potential safe vaccination approach for SARS.
 
Last edited:
Top